Research and Markets: Italy Migraine Pipeline Market Report 2013

DUBLIN–(BUSINESS WIRE)– Study and Markets (http://www.researchandmarkets.com/research/nkc56j/italy_migraine) has announced the addition of the “Italy Migraine Market Highlights – 2014” record to their providing. The current study, ‘Italy Migraine Market Highlights – 2014’, supplies Italy migraine market analysis, affordable landscape, and migraine medicine sales forecast in Italy. The research consists of Italy migraine market dimension estimations for 2013, market share projection for six years to 2019, migraine medications market share, migraine medicines sales quotes, migraine medications sales forecast, and migraine late phase …

Research and Markets: Germany Migraine Market Highlights

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/k3m9pc/germany_migraine) has announced the addition of the “Germany Migraine Market Highlights – 2014” report to their offering. The latest research, ‘Germany Migraine Market Highlights – 2014’, provides Germany migraine market analysis, competitive landscape, and migraine drug sales forecast in Germany. The research includes Germany migraine market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline …

Research and Markets: Global Ergot Alkaloids (Migraine) Report 2014

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/kwzrcj/ergot_alkaloids) has announced the addition of the “Ergot Alkaloids (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. The Ergot Alkaloids were the very first anti-migraine-specific therapy class to reach the market. The first pure ergot alkaloid was isolated in 1920, but only in 1925 was ergotamine used to successfully treat a case of severe and intractable migraine via subcutaneous injection (Rothlin, 1955; Stoll, 1965). Over the following decades, ergotamine’s use as …

Research and Markets: Global Migraine Report 2014: Zecuity Forecast and Market Analysis to 2023

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/63vbdq/zecuity) has announced the addition of the “Zecuity (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. Zecuity is the first and only skin patch approved to deliver sumatriptan in patients needing acute treatment to abort their migraines and migraine-related nausea. Zecuity uses a proprietary SmartRelief technology which uses a mild electric current to transport sumatriptan across the skin, a process called iontophoresis. It uses an electric current to pull ionized drug …

Research and Markets: Triptans (Migraine)

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/lwwcrv/triptans) has announced the addition of the “Triptans (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as …

Research and Markets: Levadex (Migraine)

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/6jlq2t/levadex) has announced the addition of the “Levadex (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as …

Research and Markets: Top Migraine Partnering Deals 2009

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/29vgsh/migraine) has announced the addition of the “Migraine Partnering 2009-2014″ report to their offering. The Migraine Partnering 2009-2014 provides understanding and access to the migraine partnering deals and agreements entered into by the world’s leading healthcare companies . The report provides an analysis of migraine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors migraine technology. These deals tend …

  • DON’T  LEAVE  EMPTY-HANDED !!!

    Download your FREE Report on Headache

    slide12t

    Just a sneak peek…

    • Guide to cluster headache
    • Why do you get a headache?
    • Headache and migraine pain relief through hypnotherapy
    • Can stress cause severe headache?
    • Caffeine: the culprit behind our migraines
    • Menopause and headaches
    • Sinusitis: how serious is it?
    Download It Completely FREE

    Just Insert Your Name and email

    We will also send you a Complimentary copy of our Headache Newsletter. Our newsletter subscription has the latest information on Headache and Migraine treatments.

    We respect your privacy. We will NEVER sell, rent or share your email address. That’s more than a policy, it’s our personal guarantee!

  • Now you can have the Latest News on Headache

    hedac02-220

    Worried about Headache and Migraine? You can have now information about the latest treatments and medical research. All this and more in our Headache Newsletter.slide11t

    Try it for four weeks. We will even send you FREE our bonus health e-book with your trial subscription.

    All for just ONE PENNY

    Get the latest information – don’t be left in the dark on your condition.

     CLICK HERE 

    Check our special offer: Subscribe to one newsletter, get another newsletter for FREE!